Molbio Diagnostics Ltd Share Price

Medical EquipmentNSE
₹1,495.50
-30.90-2.02% (1D)
As on 20 Nov 2026 at 15:59
As of 20 Nov 2026 at 15:59, Molbio Diagnostics Ltd is trading at ₹1,495.50. The 52-week range stands at ₹925.80–₹1,686.80, with a market cap of ₹17.23 thousand crore. At a P/E of 109.12 and a dividend yield of 0.00%, it is a mid-cap stock in the Healthcare sector.

MOLBIO Price Chart

Market Cap
₹17.23K Cr
PE Ratio
109.12
ROCE
—

Molbio Diagnostics Ltd Performance

Molbio Diagnostics Ltd Fundamentals

Know More
Market Cap₹17.23K Cr
ROE—
P/E Ratio (TTM)109.12
EPS (TTM)₹13.70
P/B Ratio12.16
Dividend Yield0.00%
Industry P/E188.26
Book Value₹122.94
Debt to Equity0.18
Face Value₹1

Molbio Diagnostics Ltd Shareholding Pattern

Know More
Promoter41.3%
Foreign Institutions1.6%
Mutual Funds8%
Domestic Institutions11.1%
Public38%

Molbio Diagnostics Ltd Financial Statements

Know More
No data for this view.

Molbio Diagnostics Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Apollo Hospitals Enterprise Ltd
₹9,190.05
452.05(+5.17%)
1,32,138.86,696.5 - 9,282.5
Max Healthcare Institute Ltd
₹1,079.60
38.95(+3.74%)
1,05,080.4797.0 - 1,185.4
Manipal Health Enterprises Ltd
₹702.20
5.75(+0.83%)
92,365.8597.0 - 815.0
Aster DM Quality Care Ltd
₹779.65
40.35(+5.46%)
67,959.9519.1 - 891.3
Fortis Healthcare Ltd
₹825.00
15.15(+1.87%)
62,284.1705.0 - 1,010.1

About Molbio Diagnostics

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a Private Company dated October 20, 2000. Thereafter, Company converted from private to a Public limited Company and a fresh Certificate of incorporation dated January 16, 2025 was issued by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases. The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000. Bigtec Innovations Private Limited got merged with the Company in 2015. It has developed Truenat' platform in 2015, which is a novel POC polymerase chain reaction (PCR) platform that can operate in resource limited settings since its battery operated, facilitating decentralized diagnosis within an hour. The Company works five manufacturing facilities in India, of which two are in Goa, one in Bengaluru, Karnataka and one in Visakhapatnam, Andhra Pradesh. Company is mainly engaged in the business of manufacturing chip based diagnostic devices, chips and reagents, X-ray equipment's, single / dual detector solutions, developing diagnostic devices, performing tests in the bio-sensing domain, digital pathology, etc. In addition to this, it offer products globally to public health programs, diagnostic laboratories, and private and public hospitals. In February 2023, Company acquired 65.47% of the equity share capital of Prognosys Medical Systems Pvt Ltd to venture into radiology equipment. Further, in October 2024, Company acquired a 19.68 % equity stake in OptraScan Inc., a USA based company, to diversify to digital pathology scanners. The Company came up with the IPO of 11,646,246 equity shares of Rs 1 each and raised funds of Rs 940 crore which comprise a fresh issue of 2,480,246 equity shares amounting to Rs 200 crore and the offer for sale of 9,166,000 equity shares amounting to Rs 740 crore on August 12, 2026. The Company has collaborated with Equine Biotech Private Limited for the development of veterinary diagnostic solutions in 2026.

Parent Organisation—
Founded2000
Managing Director—
NSE SymbolMOLBIO

Molbio Diagnostics Ltd Resistance and Support levels

R31,577.73R21,553.59R11,538.68S11,490.39S21,475.48S31,451.331,495.50

Molbio Diagnostics Ltd Technicals

Current Price
₹1,495.50 ₹30.90 (-2.02%)
Bearish
1
Bullish
11
  • 20 Day6.2%
  • 50 Day11.7%
  • 100 Day14.4%
  • 200 Day14.4%

Molbio Diagnostics Ltd Latest News

View More
02 NOV 2026 | Monday
Molbio Diagnostics schedules a board meeting November 5 to review financial results
08 OCT 2026 | Thursday
Molbio Diagnostics confirms electronic shareholding via KFin Technologies for September quarter
28 SEPT 2026 | Monday
Molbio Diagnostics closes trading window for insiders ahead of quarterly results
25 SEPT 2026 | Friday
Molbio Diagnostics' board re-appointed K. S. Kamalakara & Co as Cost Auditors
01 SEPT 2026 | Tuesday
Molbio Diagnostics to review quarterly results at board meeting on September 5, 2026
27 AUG 2026 | Thursday
Molbio Diagnostics appoints Darshan Karekar as Compliance Officer, per SEBI regulations
20 AUG 2026 | Thursday
Molbio Diagnostics closes trading window for insiders ahead of financial results

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced

Frequently asked questions

The share price of Molbio Diagnostics Ltd is ₹1,495.50 as of 20 Nov 2026 at 15:59.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now